146 related articles for article (PubMed ID: 20643091)
1. Is a mass immunization program for pandemic (H1N1) 2009 good value for money? Evidence from the Canadian Experience.
Sander B; Bauch CT; Fisman D; Fowler RA; Kwong JC; Maetzel A; McGeer A; Raboud J; Scales DC; Gojovic MZ; Krahn M
Vaccine; 2010 Aug; 28(38):6210-20. PubMed ID: 20643091
[TBL] [Abstract][Full Text] [Related]
2. Pandemic (H1N1) 2009 influenza vaccine roll-out in NSW.
Fizzell J; Campbell-Lloyd S; Hallett AJ; Lowbridge CP; Meijer D; Tyner SE
N S W Public Health Bull; 2010; 21(1-2):32-5. PubMed ID: 20374692
[TBL] [Abstract][Full Text] [Related]
3. Vaccines against influenza A (H1N1) pandemic.
Valdespino-Gomez JL; Garcia-Garcia L; de León-Rosales SP
Arch Med Res; 2009 Nov; 40(8):693-704. PubMed ID: 20304259
[TBL] [Abstract][Full Text] [Related]
4. Summaries for patients. Assessing the best way to prevent spread of influenza.
Ann Intern Med; 2009 Dec; 151(12):I31. PubMed ID: 20008744
[No Abstract] [Full Text] [Related]
5. A tool for the economic analysis of mass prophylaxis operations with an application to H1N1 influenza vaccination clinics.
Cho BH; Hicks KA; Honeycutt AA; Hupert N; Khavjou O; Messonnier M; Washington ML
J Public Health Manag Pract; 2011; 17(1):E22-8. PubMed ID: 21135651
[TBL] [Abstract][Full Text] [Related]
6. Design of a robust infrastructure to monitor the safety of the pandemic A(H1N1) 2009 vaccination program in Taiwan.
Huang WT; Chen WW; Yang HW; Chen WC; Chao YN; Huang YW; Chuang JH; Kuo HS
Vaccine; 2010 Oct; 28(44):7161-6. PubMed ID: 20804804
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of Ontario's pandemic vaccine program.
Rolland-Harris E; Tepper M
Vaccine; 2011 May; 29(22):3829; author reply 3830-1. PubMed ID: 20831912
[No Abstract] [Full Text] [Related]
8. Acceptance of a vaccine against pandemic influenza A (H1N1) virus amongst healthcare workers in Beijing, China.
Seale H; Kaur R; Wang Q; Yang P; Zhang Y; Wang X; Li X; Zhang H; Zhang Z; MacIntyre CR
Vaccine; 2011 Feb; 29(8):1605-10. PubMed ID: 21211593
[TBL] [Abstract][Full Text] [Related]
9. Vaccination against pandemic influenza A/H1N1v in England: a real-time economic evaluation.
Baguelin M; Hoek AJ; Jit M; Flasche S; White PJ; Edmunds WJ
Vaccine; 2010 Mar; 28(12):2370-84. PubMed ID: 20096762
[TBL] [Abstract][Full Text] [Related]
10. Safety and effectiveness of a 2009 H1N1 vaccine in Beijing.
Wu J; Xu F; Lu L; Lu M; Miao L; Gao T; Ji W; Suo L; Liu D; Ma R; Yu R; Zhangzhu J; Liu W; Zeng Y; Li X; Zhang X; Pang X; Deng Y
N Engl J Med; 2010 Dec; 363(25):2416-23. PubMed ID: 21158658
[TBL] [Abstract][Full Text] [Related]
11. Poverty, wealth, and access to pandemic influenza vaccines.
Yamada T
N Engl J Med; 2009 Sep; 361(12):1129-31. PubMed ID: 19675324
[No Abstract] [Full Text] [Related]
12. Epilogue: school-located influenza vaccination during the 2009-2010 pandemic and beyond.
Vogt TM; Wortley PM
Pediatrics; 2012 Mar; 129 Suppl 2():S107-9. PubMed ID: 22383480
[No Abstract] [Full Text] [Related]
13. [Mathematical modeling of the novel influenza A (H1N1) virus and evaluation of the epidemic response strategies in the Republic of Korea].
Suh M; Lee J; Chi HJ; Kim YK; Kang DY; Hur NW; Ha KH; Lee DH; Kim CS
J Prev Med Public Health; 2010 Mar; 43(2):109-16. PubMed ID: 20383043
[TBL] [Abstract][Full Text] [Related]
14. Pandemic influenza. Europe reconsiders H1N1 flu shots for children.
Enserink M
Science; 2009 Nov; 326(5955):922. PubMed ID: 19965485
[No Abstract] [Full Text] [Related]
15. Immunization-safety monitoring systems for the 2009 H1N1 monovalent influenza vaccination program.
Salmon DA; Akhtar A; Mergler MJ; Vannice KS; Izurieta H; Ball R; Lee GM; Vellozzi C; Garman P; Cunningham F; Gellin B; Koh H; Lurie N;
Pediatrics; 2011 May; 127 Suppl 1():S78-86. PubMed ID: 21502251
[TBL] [Abstract][Full Text] [Related]
16. Vaccination against pandemic influenza A/H1N1 among healthcare workers and reasons for refusing vaccination in Istanbul in last pandemic alert phase.
Torun SD; Torun F
Vaccine; 2010 Aug; 28(35):5703-10. PubMed ID: 20600497
[TBL] [Abstract][Full Text] [Related]
17. 2009 pandemic influenza: a review.
Faruqui F; Mukundan D
Curr Opin Pediatr; 2010 Aug; 22(4):530-5. PubMed ID: 20601883
[TBL] [Abstract][Full Text] [Related]
18. The modern crystal ball: influenza forecasting with mathematical models.
Kansagra SM; Farley TA
Ann Intern Med; 2009 Dec; 151(12):886-7. PubMed ID: 20008763
[No Abstract] [Full Text] [Related]
19. [Well-functioning strategy for the A/H1N1 pandemic in Varmland. A preliminary summary].
Wik O
Lakartidningen; 2010 Jun 16-29; 107(24-25):1630-3. PubMed ID: 20687426
[No Abstract] [Full Text] [Related]
20. Cost-effectiveness of live-attenuated influenza vaccine, trivalent in preventing influenza in young children attending day-care centres.
Hibbert CL; Piedra PA; McLaurin KK; Vesikari T; Mauskopf J; Mahadevia PJ
Vaccine; 2007 Nov; 25(47):8010-20. PubMed ID: 17936446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
